[{"Assets_0_FY_USD":205425000.0,"CommonStockSharesOutstanding_0_FY_shares":44938133.0,"EarningsPerShareBasic_4_FY_USD":-0.35,"EarningsPerShareDiluted_4_FY_USD":-0.35,"NetIncomeLoss_1_FY_USD":-1838000.0,"NetIncomeLoss_4_FY_USD":-15567000.0,"StockholdersEquity_0_FY_USD":131387000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":44735146.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":44735146.0,"Ticker":"VNDA","CIK":"1347178","name":"VANDA PHARMACEUTICALS INC.","OfficialName":"Vanda Pharmaceuticals Inc. Common Stock","form":"10-K","period":"20171231","fy":"2017.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"633424667.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180215"}]